Eaton Vance Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $26.6M | Buy |
121,700
+10,625
| +10% | +$2.32M | 0.04% | 385 |
|
|
2022
Q2 | $23.3M | Buy |
111,075
+30,610
| +38% | +$6.42M | 0.03% | 425 |
|
|
2022
Q1 | $19.5M | Buy |
80,465
+34,199
| +74% | +$8.29M | 0.02% | 506 |
|
|
2021
Q4 | $12.1M | Buy |
46,266
+1,834
| +4% | +$478K | 0.01% | 587 |
|
|
2021
Q3 | $11.1M | Sell |
44,432
-365
| -0.8% | -$91.3K | 0.02% | 548 |
|
|
2021
Q2 | $11M | Buy |
44,797
+1,685
| +4% | +$415K | 0.01% | 586 |
|
|
2021
Q1 | $8.37M | Sell |
43,112
-1,022
| -2% | -$198K | 0.01% | 601 |
|
|
2020
Q4 | $9.38M | Buy |
44,134
+163
| +0.4% | +$34.6K | 0.01% | 547 |
|
|
2020
Q3 | $7.54M | Sell |
43,971
-65
| -0.1% | -$11.1K | 0.01% | 539 |
|
|
2020
Q2 | $8.46M | Sell |
44,036
-887
| -2% | -$170K | 0.02% | 484 |
|
|
2020
Q1 | $6.62M | Sell |
44,923
-691
| -2% | -$102K | 0.02% | 484 |
|
|
2019
Q4 | $7.07M | Buy |
45,614
+21,553
| +90% | +$3.34M | 0.01% | 532 |
|
|
2019
Q3 | $3.25M | Sell |
24,061
-297
| -1% | -$40.1K | 0.01% | 690 |
|
|
2019
Q2 | $2.97M | Sell |
24,358
-555
| -2% | -$67.7K | 0.01% | 711 |
|
|
2019
Q1 | $2.59M | Sell |
24,913
-45,087
| -64% | -$4.69M | 0.01% | 708 |
|
|
2018
Q4 | $7.97M | Buy |
70,000
+130
| +0.2% | +$14.8K | 0.02% | 418 |
|
|
2018
Q3 | $8.06M | Buy |
69,870
+4,677
| +7% | +$539K | 0.02% | 456 |
|
|
2018
Q2 | $6.75M | Sell |
65,193
-51,059
| -44% | -$5.29M | 0.02% | 473 |
|
|
2018
Q1 | $11.4M | Buy |
116,252
+100,252
| +627% | +$9.87M | 0.01% | 490 |
|
|
2017
Q4 | $1.36M | Hold |
16,000
| – | – | ﹤0.01% | 778 |
|
|
2017
Q3 | $1.23M | Hold |
16,000
| – | – | ﹤0.01% | 780 |
|
|
2017
Q2 | $1.25M | Buy |
+16,000
| New | +$1.25M | ﹤0.01% | 770 |
|